Highly selective anthraquinone-chalcone hybrids as potential antileukemia agents
Authorized Users Only
AuthorsStanojković, Tatjana P.
Matić, Ivana Z.
Mladenović, Milan P.
Krivokuća, Ana M.
Petković, Miloš R.
Joksović, Milan D.
Article (Published version)
© 2018 Elsevier Ltd
MetadataShow full item record
A series of 23 novel anthraquinone-chalcone hybrids containing amide function was synthesized and structurally characterized. Sixteen compounds exerted strong cytotoxic activities against K562, Jurkat and HL-60 leukemia cell lines and significantly lower cytotoxic effects against normal MRC-5 cells, indicating very high selectivity in their anticancer action. The compounds 6g, 6u and 6v activate apoptosis in K562 cells through the extrinsic and intrinsic apoptotic pathway. The compound 6e triggered apoptosis in K562 cells only through the extrinsic apoptotic pathway. Treatment of K562 cells with each of these four compounds caused decrease in the expression levels of MMP2, MMP9, and VEGF, suggesting their anti-invasive, antimetastatic and antiangiogenic properties. The compounds 6g and 6v downregulated expression levels of miR-155 in K562 cells, while compounds 6e and 6u upregulated miR-155 levels in treated cells, in comparison with control cells. The structure-based 3-D QSAR models f...or 6f, 6e, 6i and 6l describe pro-apoptotic activity against caspase-3. © 2018 Elsevier Ltd
Keywords:anthraquinone-chalcone / leukemia / gene expression / miR-155 / 3-D QSAR
Source:Bioorganic & Medicinal Chemistry Letters, 2018, 28, 15, 2593-2598
- Synthesis, modeling, physicochemical and biological properties of organic compounds and related metal complexes (RS-172016)
- Biological response modifiers in physiological and pathological conditions (RS-175011)
ISSN: 0960-894X (print); 1464-3405 (electronic)